Polymorphisms of TNF-alpha and LT-alpha genes in multiple myeloma.

[1]  R. Ádány,et al.  The 8.1 ancestral MHC haplotype is strongly associated with colorectal cancer risk , 2007, International journal of cancer.

[2]  L. Staudt,et al.  Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma. , 2007, Cancer cell.

[3]  L. Bruhn,et al.  Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma. , 2007, Cancer cell.

[4]  N. Rothman,et al.  Common variants in genes that mediate immunity and risk of multiple myeloma , 2007, International journal of cancer.

[5]  C. Caruso,et al.  Genetic Control of Immune Response in Carriers of Ancestral Haplotype 8.1 , 2006, Annals of the New York Academy of Sciences.

[6]  M. Rewers,et al.  Extreme genetic risk for type 1A diabetes , 2006, Proceedings of the National Academy of Sciences.

[7]  B. Melegh,et al.  Decreased frequency of the TNF2 allele of TNF-alpha -308 promoter polymorphism is associated with lacunar infarction. , 2006, Cytokine.

[8]  K. Welsh,et al.  MHC class II, tumour necrosis factor α, and lymphotoxin α gene haplotype associations with serological subsets of systemic lupus erythematosus , 2005, Annals of the rheumatic diseases.

[9]  B. Burkhardt,et al.  Tumor necrosis factor and lymphotoxin alfa genetic polymorphisms and outcome in pediatric patients with non-Hodgkin's lymphoma: results from Berlin-Frankfurt-Münster Trial NHL-BFM 95. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  E. Thorsby,et al.  Systemic lupus erythematosus and the extended major histocompatibility complex--evidence for several predisposing loci. , 2005, Rheumatology.

[11]  S. Rollinson,et al.  Haplotypes in the tumour necrosis factor region and myeloma , 2005, British journal of haematology.

[12]  R. Ádány,et al.  A preliminary evaluation of a health monitoring programme in Hungary. , 2005, European journal of public health.

[13]  K. Calame,et al.  Plasma cell differentiation and multiple myeloma. , 2004, Current opinion in immunology.

[14]  E. Khusnutdinova,et al.  Molecular Genetic Analysis of the Interleukin 6 and Tumor Necrosis Factor α Gene Polymorphisms in Multiple Myeloma , 2003, Molecular Biology.

[15]  M. Cuccia,et al.  Pathogenesis of autoimmune diseases associated with 8.1 ancestral haplotype: a genetically determined defect of C4 influences immunological parameters of healthy carriers of the haplotype. , 2003, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[16]  H. Goldschmidt,et al.  Polymorphisms of the tumor necrosis factor-alpha gene promoter predict for outcome after thalidomide therapy in relapsed and refractory multiple myeloma. , 2002, Blood.

[17]  C. Caruso,et al.  Pathogenesis of autoimmune diseases associated with 8.1 ancestral haplotype: effect of multiple gene interactions. , 2002, Autoimmunity reviews.

[18]  Ruben Gamboa,et al.  Heat shock protein 70 gene polymorphisms in Mexican patients with spondyloarthropathies , 2002, Annals of the rheumatic diseases.

[19]  M. Čolović,et al.  Correlation of sera TNF-alpha with percentage of bone marrow plasma cells, LDH, beta2-microglobulin, and clinical stage in multiple myeloma. , 2002, Medical Oncology.

[20]  P. Grant,et al.  Effects of novel polymorphisms in the RAGE gene on transcriptional regulation and their association with diabetic retinopathy. , 2001, Diabetes.

[21]  R. Locksley,et al.  The TNF and TNF Receptor Superfamilies Integrating Mammalian Biology , 2001, Cell.

[22]  E Roman,et al.  High-producer haplotypes of tumor necrosis factor alpha and lymphotoxin alpha are associated with an increased risk of myeloma and have an improved progression-free survival after treatment. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  M. Björkholm,et al.  Interleukin 6, tumour necrosis factor α, interleukin 1β and interleukin 1 receptor antagonist promoter or coding gene polymorphisms in multiple myeloma , 2000 .

[24]  M. Björkholm,et al.  Interleukin 6, tumour necrosis factor alpha, interleukin 1beta and interleukin 1 receptor antagonist promoter or coding gene polymorphisms in multiple myeloma. , 2000, British journal of haematology.

[25]  K. Tarte,et al.  Tumor necrosis factor is a survival and proliferation factor for human myeloma cells. , 1999, European cytokine network.

[26]  M. Walker,et al.  Tumour necrosis factor-alpha gene promoter polymorphism and decreased insulin resistance , 1998, Diabetologia.

[27]  H. Mcdevitt,et al.  Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[28]  T. Espevik,et al.  THE ROLE OF THE TWO TNF RECEPTORS IN PROLIFERATION, NF-κB ACTIVATION AND DISCRIMINATION BETWEEN TNF AND LTαSIGNALLING IN THE HUMAN MYELOMA CELL LINE OH-2 , 1996 .

[29]  T. Espevik,et al.  The role of the two TNF receptors in proliferation, NF-kappa B activation and discrimination between TNF and LT alpha signalling in the human myeloma cell line OH-2. , 1996, Cytokine.

[30]  A. Waage,et al.  TNF and IL‐6 are potent growth factors for OH‐2, a novel human myeloma cell line , 1994, European journal of haematology.

[31]  I. Udalova,et al.  DNA sequence polymorphism at the human tumor necrosis factor (TNF) locus. Numerous TNF/lymphotoxin alleles tagged by two closely linked microsatellites in the upstream region of the lymphotoxin (TNF-beta) gene. , 1991, Journal of immunology.

[32]  U. Spengler,et al.  Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF- beta production , 1991, The Journal of experimental medicine.

[33]  Shirley A. Miller,et al.  A simple salting out procedure for extracting DNA from human nucleated cells. , 1988, Nucleic acids research.

[34]  D. Goeddel,et al.  Human lymphotoxin and tumor necrosis factor genes: structure, homology and chromosomal localization. , 1985, Nucleic acids research.

[35]  J. McCluskey,et al.  Disease Associations with Complotypes, Supratypes and Haplotypes , 1983, Immunological reviews.

[36]  S. Salmon,et al.  A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival , 1975, Cancer.